 |
|
Clinical outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C
Korean J Hepatol. 2008;14(1):36-45. Published online 2008 Mar 20 DOI: https://doi.org/10.3350/kjhep.2008.14.1.36
|
|
Citations to this article as recorded by
 Revisiting policy on chronic HCV treatment under the Thai Universal Health Coverage: An economic evaluation and budget impact analysis
Waranya Rattanavipapong, Thunyarat Anothaisintawee, Yot Teerawattananon, Jee-Fu Huang
PLOS ONE.2018; 13(2): e0193112. CrossRef All‐oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub‐analysis in Asian patients from the HALLMARK DUAL study
Jia‐Horng Kao, Youn‐Jae Lee, Jeong Heo, Sang‐Hoon Ahn, Young‐Suk Lim, Cheng‐Yuan Peng, Ting‐Tsung Chang, Anne Torbeyns, Eric Hughes, Rafia Bhore, Stephanie Noviello
Liver International.2016; 36(10): 1433. CrossRef Genotype 3 is the predominant hepatitis C genotype in a multi-ethnic Asian population in Malaysia
Shiaw-Hooi Ho, Kee-Peng Ng, Harvinder Kaur, Khean-Lee Goh
Hepatobiliary & Pancreatic Diseases International.2015; 14(3): 281. CrossRef Lower Incidence of Hepatocellular Carcinoma and Cirrhosis in Hepatitis C Patients with Sustained Virological Response by Pegylated Interferon and Ribavirin
Chansoo Moon, Kyu Sik Jung, Do Young Kim, Oidov Baatarkhuu, Jun Yong Park, Beom Kyung Kim, Seung Up Kim, Sang Hoon Ahn, Kwang-Hyub Han
Digestive Diseases and Sciences.2015; 60(2): 573. CrossRef The Depression Predictors among Patients with Peg-interferon Treated Hepatitis C
Ha-Na Kim, Eun-Nam Lee
Korean Journal of Adult Nursing.2014; 26(2): 214. CrossRef Advanced fibrosis is not a negative pretreatment predictive factor for genotype 2 or 3 chronic hepatitis C patients
Hyun Seok Lee, Young Oh Kweon, Won Young Tak, Soo Young Park, Eun Jung Kang, Yu Lim Lee, Hae Min Yang, Hyun Woo Park
Clinical and Molecular Hepatology.2013; 19(2): 148. CrossRef Efficacy and Tolerability of Peginterferon Alpha Plus Ribavirin in the Routine Daily Treatment of Chronic Hepatitis C Patients in Korea: A Multi-Center, Retrospective Observational Study
Sang Hoon Park, Choong Kee Park, Jin Woo Lee, Young Seok Kim, Sook-Hyang Jeong, Yun Soo im, Ju Hyun Kim, Seong Gyu Hwang, Kyu Sung Rim, Hyung Joon Yim, Jae Youn Cheong, Sung Won Cho, June Sung Lee, Young Min Park, Jeong Won Jang Chun Kyon Lee, Joo Hyun Sh
Gut and Liver.2012; 6(1): 98. CrossRef Recent trends in the treatment of chronic hepatitis C
Dae Won Jun, Won Young Tak, Si Hyun Bae, Youn Jae Lee
The Korean Journal of Hepatology.2012; 18(1): 22. CrossRef Efficacy of Peginterferon and Ribavirin Combination Therapy of Chronic Hepatitis C: A Pooled Analysis
Soo Yong Park, Min Young Rim, In Ku Yo, Min Su Ha, Ju Seung Kim, Ji Won Lee, Young Kul Jung, Oh Sang Kwon, Yun Soo Kim, Duck Joo Choi, Ju Hyun Kim
The Korean Journal of Gastroenterology.2012; 60(5): 306. CrossRef A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C
Byung Chul You, Young Seok Kim, Hun il Kim, Se Hun Kim, Seung Sik Park, Yu Ri Seo, Sang Gyune Kim, Se Whan Lee, Hong Soo Kim, Soung Won Jeong, Jae Young Jang, Boo Sung Kim
Clinical and Molecular Hepatology.2012; 18(3): 272. CrossRef Peginterferon alpha and ribavirin combination therapy in patients with hepatitis C virus-related liver cirrhosis
Kyung Hoon Kim, Byoung Kuk Jang, Woo Jin Chung, Jae Seok Hwang, Young Oh Kweon, Won Young Tak, Heon Ju Lee, Chang Hyeong Lee, Jeong Ill Suh
The Korean Journal of Hepatology.2011; 17(3): 220. CrossRef Antiviral Therapy in Patients after Treatment for Hepatitis C-Related Hepatocellular Carcinoma
Su Rin Shin, Seung Woon Paik, Geum-Youn Gwak, Moon Seok Choi, Joon Hyoek Lee, Kwang Cheol Koh, Byung Chul Yoo
Gut and Liver.2011; 5(1): 77. CrossRef Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus
Yu Jin Kim, Jin Woo Lee, Yun Soo Kim, Sook-Hyang Jeong, Young Seok Kim, Hyung Joon Yim, Bo Hyun Kim, Chun Kyon Lee, Choong Kee Park, Sang Hoon Park
The Korean Journal of Hepatology.2011; 17(3): 199. CrossRef Risk factors for relapse in chronic hepatitis C patients who have achieved end of treatment response
Su Rin Shin, Dong Hyun Sinn, Geum‐Youn Gwak, Moon Seok Cho, Joon Hyoek Lee, Kwang Cheol Koh, Byung Chul Yoo, Seung Woon Paik
Journal of Gastroenterology and Hepatology.2010; 25(5): 957. CrossRef Current status of liver disease in Korea: Hepatitis C
Young-Suk Lim
The Korean Journal of Hepatology.2009; 15(Suppl 6): S25. CrossRef Vitamins B depletion, lower iron status and decreased antioxidative defense in patients with chronic hepatitis C treated by pegylated interferon alfa and ribavirin
Chun-che Lin, Mei-chin Yin
Clinical Nutrition.2009; 28(1): 34. CrossRef Durability of a sustained virologic response in combination therapy with interferon/peginterferon and ribavirin for chronic hepatitis C
Chul Hyun Kim, Byung Do Park, Jin Woo Lee, Young Soo Kim, Seok Jeong, Don Haeng Lee, Hyung Gil Kim, Yong Woon Shin, Key Sook Kwon, Jung Il Lee
The Korean Journal of Hepatology.2009; 15(1): 70. CrossRef Treatment of chronic hepatitis C in Asia: When East meets West
Ming‐Lung Yu, Wan‐Long Chuang
Journal of Gastroenterology and Hepatology.2009; 24(3): 336. CrossRef Effects of pegylated interferon and ribavirin in Korean patients with chronic hepatitis C virus infection
Myoung Joo Kang, Eun Uk Jung, Sang Won Park, Paul Choi, Ji Hyun Kim, Sung Jae Park, Eun Taek Park, Youn Jae Lee, Sang Hyuk Lee, Sang Yong Seol
The Korean Journal of Hepatology.2008; 14(3): 318. CrossRef Efficacy of initial treatment with peginterferon alpha-2a versus peginterferon alpha-2b in combination with ribavirin in naive chronic hepatitis C patients living in Daejeon and Chungcheong Province in Korea: A comparative study
Jeong Il Kim, Seok Hyun Kim, Byung Seok Lee, Heon Young Lee, Tae Hee Lee, Young Woo Kang, Hyang Ie Lee, An Na Kim, Soon Woo Nam, Byeong Chool Park, Hee Bok Chae, Seok Bae Kim, Il Han Song, Ji Young Park, Hong Su Kim
The Korean Journal of Hepatology.2008; 14(4): 493. CrossRef Treatment of chronic hepatitis C: Efficacy of initial treatment of peginterferon alpha-2a versus peginterferon alpha-2b plus ribavirin in naive chronic hepatitis C patients
Youn Jae Lee
The Korean Journal of Hepatology.2008; 14(4): 443. CrossRef
|